IL91304A0 - Recombinant vaccinia virus for prevention of disease caused by flavivirus - Google Patents
Recombinant vaccinia virus for prevention of disease caused by flavivirusInfo
- Publication number
- IL91304A0 IL91304A0 IL91304A IL9130489A IL91304A0 IL 91304 A0 IL91304 A0 IL 91304A0 IL 91304 A IL91304 A IL 91304A IL 9130489 A IL9130489 A IL 9130489A IL 91304 A0 IL91304 A0 IL 91304A0
- Authority
- IL
- Israel
- Prior art keywords
- flavivirus
- prevention
- vaccinia virus
- disease caused
- recombinant vaccinia
- Prior art date
Links
- 241000710831 Flavivirus Species 0.000 title 1
- 241000700618 Vaccinia virus Species 0.000 title 1
- 230000006806 disease prevention Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23920588A | 1988-08-20 | 1988-08-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL91304A0 true IL91304A0 (en) | 1990-03-19 |
Family
ID=22901085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL91304A IL91304A0 (en) | 1988-08-20 | 1989-08-14 | Recombinant vaccinia virus for prevention of disease caused by flavivirus |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0431064A4 (en) |
| JP (1) | JPH03503364A (en) |
| AU (1) | AU624863B2 (en) |
| IL (1) | IL91304A0 (en) |
| WO (1) | WO1990001946A1 (en) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7767449B1 (en) | 1981-12-24 | 2010-08-03 | Health Research Incorporated | Methods using modified vaccinia virus |
| US6676936B1 (en) | 1988-07-14 | 2004-01-13 | The United States Of America As Represented By The Department Of Health And Human Services. | Chimeric and/or growth-restricted flaviviruses |
| US6184024B1 (en) | 1988-07-14 | 2001-02-06 | The United States Of America As Represented By The Department Of Health And Human Services | Chimeric and/or growth-restricted flaviviruses |
| CA2018332A1 (en) * | 1989-06-06 | 1990-12-06 | Franz X. Heinz | Proteins, vaccines and nucleic acids |
| MY109299A (en) * | 1990-08-15 | 1996-12-31 | Virogenetics Corp | Recombinant pox virus encoding flaviviral structural proteins |
| ES2254055T3 (en) * | 1991-09-19 | 2006-06-16 | The United States Of America, As Represented By The Secretary, Departm. Of Health And Human Services | CHIMERIC FLAVIVIRUS AND / OR RESTRICTED GROWTH. |
| US6117640A (en) * | 1995-05-02 | 2000-09-12 | The United States Of America As Represented By The Secretary Of The Army | Recombinant vaccine made in E. coli against dengue virus |
| WO1996037221A1 (en) * | 1995-05-24 | 1996-11-28 | Hawaii Biotechnology Group, Inc. | Subunit vaccine against flavivirus infection |
| US6869793B2 (en) | 1996-09-24 | 2005-03-22 | Bavarian Nordic Research Institute | Recombinant MVA virus expressing dengue virus antigens, and the use thereof in vaccines |
| CZ300172B6 (en) * | 1997-02-28 | 2009-03-04 | Acambis Inc. | Chimeric live, infectious, attenuated virus, medicament for prevention or treatment of flavivirus infections and nucleic acid moleculre encoding thereof |
| US7227011B2 (en) | 1998-06-04 | 2007-06-05 | United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention | Nucleic acid vaccines for prevention of flavivirus infection |
| JP4489943B2 (en) | 1998-06-04 | 2010-06-23 | アメリカ合衆国 | Nucleic acid vaccine for prevention of flavivirus infection |
| AU3844101A (en) | 2000-02-16 | 2001-08-27 | Us Health | Avirulent, immunogenic flavivirus chimeras |
| EP1456230A2 (en) * | 2001-12-04 | 2004-09-15 | Bavarian Nordic A/S | Flavivirus ns1 subunit vaccine |
| CA2432738A1 (en) | 2003-02-26 | 2004-08-26 | Philippe Despres | New dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications |
| CA3177574A1 (en) | 2013-03-15 | 2014-09-25 | Takeda Vaccines, Inc. | Compositions and methods for dengue virus chimeric constructs in vaccines |
| CA3111332A1 (en) | 2018-09-05 | 2020-03-12 | Takeda Vaccines, Inc. | Dengue vaccine unit dose and administration thereof |
| US11464815B2 (en) | 2018-09-05 | 2022-10-11 | Takeda Vaccines, Inc. | Dengue vaccine unit dose and administration thereof |
| US11426461B2 (en) | 2018-09-05 | 2022-08-30 | Takeda Vaccines, Inc. | Methods for preventing dengue and hepatitis A |
| EP3939607A4 (en) * | 2019-03-14 | 2023-01-25 | Tokyo Metropolitan Institute of Medical Science | Dengue virus vaccine |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH084508B2 (en) * | 1987-09-16 | 1996-01-24 | 国立予防衛生研究所長 | Recombinant vaccinia virus |
-
1989
- 1989-08-14 IL IL91304A patent/IL91304A0/en unknown
- 1989-08-21 JP JP1509348A patent/JPH03503364A/en active Pending
- 1989-08-21 AU AU42064/89A patent/AU624863B2/en not_active Ceased
- 1989-08-21 WO PCT/US1989/003589 patent/WO1990001946A1/en not_active Application Discontinuation
- 1989-08-21 EP EP19890910317 patent/EP0431064A4/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP0431064A1 (en) | 1991-06-12 |
| WO1990001946A1 (en) | 1990-03-08 |
| EP0431064A4 (en) | 1991-11-13 |
| AU4206489A (en) | 1990-03-23 |
| AU624863B2 (en) | 1992-06-25 |
| JPH03503364A (en) | 1991-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0431064A4 (en) | Recombinant vaccinia virus for prevention of disease caused by flavivirus | |
| GB9303023D0 (en) | Flavivirus recombinant poxvirus vaccine | |
| AR241939A1 (en) | Recombinant avipox virus | |
| GB8821528D0 (en) | Recombinant vaccinia virus | |
| ATA902590A (en) | RECOMBINANT SMALL VIRUS | |
| ATA257190A (en) | VIRAL POLYPEPTIDE | |
| DK603888D0 (en) | RECOMBINANT VIRUS | |
| IT1239987B (en) | SPECTRUM SELECTION SYSTEM OF INFECTIVITY OF RECOMBINANT POXVIRUS | |
| NO892251L (en) | PROCEDURE FOR THE PREPARATION OF COCOCOIDOSE VACCINE BY RECOMBINANT TECHNIQUES. | |
| ZA878877B (en) | Treatment of diseases caused by viruses | |
| HU912526D0 (en) | Recombinant marek-type disease virus | |
| DK197989D0 (en) | peptide analogs | |
| IL93367A0 (en) | Fine-grained microstructure processor | |
| EP0450100A4 (en) | Physiologically active peptide | |
| GB8716953D0 (en) | Restricting movement of lever | |
| GB8916391D0 (en) | Preparation of polyacetals | |
| ITMI931371A0 (en) | PROCEDURE FOR THE PREPARATION OF ERDOSTEINE | |
| EP0428103A3 (en) | Prevention of glycoprotein enveloped virus infectivity by pyridyloxazole-2-ones | |
| GB8819884D0 (en) | Syringe for preparation of casting patterns | |
| GB8914680D0 (en) | Prevention of aid virus | |
| ITMI910861A0 (en) | IMPROVED PROCEDURE FOR THE PREPARATION OF MATURE POLYPEPTIDES | |
| IL84541A0 (en) | Pharmaceutical composition for treating a disease caused by virus | |
| IE870898L (en) | Recombinant vaccinia virus. | |
| IE883428L (en) | Dsrn based prevention of viral escape | |
| IE892593L (en) | Treatment of virus diseases |